Text: THE STRUCTURE OF THE COMPLEX WAS DETERMINED BY ALLOWING THE CDRS OF THE 0.5B ANTIBODY AND THE V3 PEPTIDE RESIDUES TO MOVE WHILE THE FRAMEWORK OF THE ANTIBODY WAS MODELED AS DESCRIBED.
-
試料調製
試料状態
イオン強度: 10 mM sodium phosphate buffer mM / pH: 7.15 / 圧: 1 atm / 温度: 305 K
結晶化
*PLUS
手法: other / 詳細: NMR
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker DRX
Bruker
DRX
800
1
Bruker DMX
Bruker
DMX
600
2
-
解析
NMR software
名称
バージョン
開発者
分類
X-PLOR
3.8
BRUNGER
精密化
NMRDraw
構造決定
NMRView
構造決定
X-PLOR
3.8
構造決定
精密化
ソフトェア番号: 1 詳細: THE STRUCTURE OF THE COMPLEX WAS DETERMINED ALLOWING THE ANTIBODY CDR RESIDUES AND THE COMPLEXED V3 PEPTIDE RESIDUES TO MOVE, WHILE THE ANTIBODY FRAMEWORK WAS HELD FIXED DURING REFINEMENT AND ...詳細: THE STRUCTURE OF THE COMPLEX WAS DETERMINED ALLOWING THE ANTIBODY CDR RESIDUES AND THE COMPLEXED V3 PEPTIDE RESIDUES TO MOVE, WHILE THE ANTIBODY FRAMEWORK WAS HELD FIXED DURING REFINEMENT AND MODELED AS DESCRIBED PREVIOUSLY